Alyeska Investment Group L.P. 13D and 13G filings for Marker Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 8:08 pm Purchase | 2025-09-30 | 13G | Marker Therapeutics, Inc. MRKR | Alyeska Investment Group L.P. | 1,280,952 9.900% | 211,293 (+19.75%) | Filing |
| 2025-02-14 4:26 pm Purchase | 2024-12-31 | 13G | Marker Therapeutics, Inc. MRKR | Alyeska Investment Group L.P. | 1,069,659 9.990% | 1,069,659 (New Position) | Filing |